States and territories can apply through Aug. 13 for a portion of $930 million in fiscal year 2018 grants to support prevention, treatment and recovery services for individuals with opioid use disorder. “This large new grant program reflects President Trump’s deep commitment to fighting the opioid crisis, and will provide extra support for the hardest-hit states,” said Health and Human Services Secretary Alex Azar. “It demonstrates the emphasis we place on expanding access to treatment that works, especially medication-assisted treatment with appropriate social supports.” In other opioid-related news, the Food and Drug Administration yesterday approved the first generic versions of a buprenorphine and naloxone film applied under the tongue to treat opioid dependence. The medication-assisted treatment can only be prescribed by certified practitioners.

Related News Articles

Headline
The Department of Health and Human Services this week awarded $487 million in fiscal year 2019 grants to help states and territories increase access to…
Headline
The three medications approved by the Food and Drug Administration to treat opioid use disorder — methadone, buprenorphine and extended-release naltrexone —…
Headline
In a study of Blue Cross and Blue Shield enrollees reported last week in the New England Journal of Medicine, initial opioid prescriptions declined 54 percent…
Headline
The House Energy and Commerce Health Subcommittee today held a hearing on the president’s fiscal year 2020 budget request for the Department of Health and…
Headline
Eligible organizations can apply through May 6 for up to $1 million each for a three-year period to expand opioid and other substance use disorder services in…
Insights and Analysis
Birmingham VA Medical Center’s weekly, 90-minute shared medical appointments help veterans address opioid reliance.